Taoka Chemical Company, Limited provided earnings guidance for the six months of the fiscal year ending March 31, 2025, and the full year ending March 31, 2025. For the six months of the fiscal year ending March 31, 2025, the company expects sales revenue of ¥15,000 million, Operating income of ¥700 million, Net income attributable to owners of the parent of ¥500 million or ¥34.89 per share.

For the year ending March 31, 2025, the company expects sales revenue of ¥30,000 million, Operating income of ¥1,200 million, Net income attributable to owners of the parent of ¥900 million or ¥62.81 per share.